Clix Capital partners with Wadhwani Foundation to support MSMEs

Under the Wadhwani Sahayata Business Stability programme, Clix Capital and Wadhwani Foundation will select 2,000 MSME partners and provide them one-on-one mentorship from experts and access to consultants and advisors for finding solutions to MSME's key business challenges.

PTI

July 07, 2020 / 07:59 PM IST

Representative image

Pramod Bhasin-founded Clix Capital has partnered with Wadhwani Foundation to provide assistance to medium, small and micro enterprises (MSMEs) to help them grow in the current crisis caused by the coronavirus pandemic.

Wadhwani Foundation is a global non-profit organisation that focuses on accelerating job creation in the country and other emerging economies through large-scale initiatives in entrepreneurship, small business growth, innovation, and skilling.

Under the Wadhwani Sahayata Business Stability programme, Clix Capital and Wadhwani Foundation will select 2,000 MSME partners and provide them one-on-one mentorship from experts and access to consultants and advisors for finding solutions to MSME's key business challenges.

Under the programme, MSMEs will receive personalised, actionable content in the form of videos, readings, articles, playbooks and infographics curated by the Wadhwani Foundation, the release said.

"Through our partnership with the Wadhwani Foundation, we aim to create a support programme to plug the skill gap for our MSME partners with measurable outcomes," Bhasin said.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show